Search

everythinglearnresearchcommunity

for

Search:↓

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Women with PCOS and hair loss have lower levels of the protein gelsolin in their blood.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Bioactive compounds in neurocosmetics can improve skin health and emotional well-being.

Anti-androgen drugs can help reduce OCD symptoms, but more large-scale trials are needed to confirm their effectiveness.

Hair loss is common in women with PCOS and is linked to symptoms like acne and excess hair but not to worse metabolic health.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Combined oral contraceptives improve skin, hormone levels, and quality of life in women with PCOS.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.

Women with nonclassical congenital adrenal hyperplasia may have a higher risk of fertility issues and miscarriages, and should get genetic counseling.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Oral contraceptives with desogestrel and drospirenone improve PCOS symptoms.

Ginseng is possibly safe but its effectiveness is unclear due to poor quality studies and mixed results.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

A higher testosterone/dihydrotestosterone ratio in PCOS patients may indicate worse metabolic health.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

There's no significant link between blood fat levels and male pattern baldness.

Hormonal imbalances, especially high androgen levels and insulin resistance, are linked to worse acne in adult women.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Patients with androgenetic alopecia often have abnormal lipid levels, so they should be screened and advised on lifestyle changes to prevent heart issues.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Hair loss is a common side effect of hormone treatments for cancer.

Dermatological conditions are complex and treatments often have mixed results.